Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Argiropoulos

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Leukemia Research|December 7, 2010
Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusionsEric Yung, Sanja Sekulovic, Bob Argiropoulos, et al.
American Journal of Medical Genetics. Part A|March 19, 2011
Discordant phenotypes in a mother and daughter with mosaic supernumerary ring chromosome 19 explained by a de novo 7q36.2 deletion and 7p22.1 duplicationBob Argiropoulos, Melissa Carter, Kathy Brierley, et al.
Cancer Genetics|June 20, 2016
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaHilary Racher, Sameh Soliman, Bob Argiropoulos, et al.
The New England Journal of Medicine|March 21, 2019
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the <i>GC</i> GeneClark M Henderson, Susan L Fink, Hanan Bassyouni, et al.
Stem Cell Research & Therapy|January 13, 2021
Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactorsBreanna S Borys, Tiffany Dang, Tania So, et al.
Nature Medicine|November 10, 2009
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotypeDaniel T Starczynowski, Florian Kuchenbauer, Bob Argiropoulos, et al.
Blood|March 19, 2010
Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3Bob Argiropoulos, Eric Yung, Ping Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypesCarola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, et al.
Stem Cell Research & Therapy|July 29, 2024
Robust bioprocess design and evaluation of commercial media for the serial expansion of human induced pluripotent stem cell aggregate cultures in vertical-wheel bioreactorsBreanna S Borys, Tiffany Dang, Hannah Worden, et al.
Blood|May 15, 2007
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AMLMichael Heuser, Bob Argiropoulos, Florian Kuchenbauer, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Leukemia Research|December 7, 2010
Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusionsEric Yung, Sanja Sekulovic, Bob Argiropoulos, et al.
American Journal of Medical Genetics. Part A|March 19, 2011
Discordant phenotypes in a mother and daughter with mosaic supernumerary ring chromosome 19 explained by a de novo 7q36.2 deletion and 7p22.1 duplicationBob Argiropoulos, Melissa Carter, Kathy Brierley, et al.
Cancer Genetics|June 20, 2016
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaHilary Racher, Sameh Soliman, Bob Argiropoulos, et al.
The New England Journal of Medicine|March 21, 2019
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the <i>GC</i> GeneClark M Henderson, Susan L Fink, Hanan Bassyouni, et al.
Stem Cell Research & Therapy|January 13, 2021
Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactorsBreanna S Borys, Tiffany Dang, Tania So, et al.
Nature Medicine|November 10, 2009
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotypeDaniel T Starczynowski, Florian Kuchenbauer, Bob Argiropoulos, et al.
Blood|March 19, 2010
Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3Bob Argiropoulos, Eric Yung, Ping Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypesCarola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, et al.
Stem Cell Research & Therapy|July 29, 2024
Robust bioprocess design and evaluation of commercial media for the serial expansion of human induced pluripotent stem cell aggregate cultures in vertical-wheel bioreactorsBreanna S Borys, Tiffany Dang, Hannah Worden, et al.
Blood|May 15, 2007
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AMLMichael Heuser, Bob Argiropoulos, Florian Kuchenbauer, et al.
Pageof 5